|
|
 | | | |
- close
- close
- close
- close
Recordati (BIT:REC) |
Marketwire
May 8
Comment
MILAN, ITALY -- (Marketwire) -- 05/08/12 -- -- Consolidated revenue EUR 219.6 million, + 11.0%. -- Operating income EUR 47.6 million, + 7.5%. -- Net income EUR 33.8 million, + 7.5%. -- Net financial position*: net debt of EUR 54.1 million. -- Start
Marketwire
Apr 24
Comment
MILAN, ITALY -- (Marketwire) -- 04/24/12 -- Recordati announces the acquisition of the marketing authorizations, the trademarks and additional assets concerning six OTC pharmaceuticals for Germany from Cilag GmbH International and McNeil GmbH & Co.
Marketwire
Apr 19
Comment
MILAN, ITALY -- (Marketwire) -- 04/19/12 -- RECORDATI: SHAREHOLDERS APPROVE THE 2011 ACCOUNTS. DIVIDEND EUR 0.30 PER SHARE. * Shareholders approve the 2011 results: Consolidated revenue EUR 762.0 million, + 4.7%, operating income EUR 163.5 million, +
Globe Newswire
Feb 21
Comment
MILAN, Italy and HASBROUCK HEIGHTS, N.J., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Recordati (Borsa Italiana:REC.MI) and Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today the start of activities aimed to the preparation of a European Phase III
Marketwire
Feb 9
Comment
MILAN, ITALY -- (Marketwire) -- 02/09/12 -- * Consolidated revenue EUR 762.0 million, + 4.7%. * Operating income EUR 163.5 million, + 5.6%. * Net income EUR 116.4 million, + 7.2%. * Net financial position*: net debt of EUR 55.7 million. *
Marketwire
Nov 29
Comment
MILAN, ITALY -- (Marketwire) -- 11/29/11 -- Pursuant to Article 2.6.2, paragraph 1, letter c) of Borsa Italiana S.p.A.'s Regulation, Recordati S.p.A. hereby communicates the calendar of corporate events for 2012. 9(th) February Board of Directors'
Marketwire
Sep 15
Comment
MILAN, ITALY -- (Marketwire) -- 09/15/11 -- Recordati announces the successful conclusion of the acquisition of 100% of the share capital of Dr. F. Frik Ilac A.S., a Turkish pharmaceutical company with headquarters in Istanbul, disclosed on 1 July
Marketwire
Jul 4
Comment
MILAN, ITALY -- (Marketwire) -- 07/04/11 -- Recordati announces the signature of the agreements covering the acquisition of 100% of the share capital of Dr. F. Frik Ilac; A.S., a Turkish pharmaceutical company with headquarters in Istanbul. The value
Marketwire
Mar 9
Comment
MILAN, ITALY -- (Marketwire) -- 03/09/11 -- * Consolidated revenue EUR 728.1 million, -2.6%. * Operating income EUR 154.8 million, -4.6%, (21.3% of total revenue) * Net income EUR 108.6 million, -1.8%, (14.9% of total revenue) * Net financial
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
